- Home
- ANGO
ANGO
AngioDynamics Inc.
as of 12-18-2025 3:39pm EST
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.
| Founded: | 1988 | Country: | United States |
| Employees: | N/A | City: | LATHAM |
| Market Cap: | 400.8M | IPO Year: | 2004 |
| Target Price: | $19.33 | AVG Volume (30 days): | 472.3K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.78 | EPS Growth: | N/A |
| 52 Week Low/High: | $8.27 - $13.99 | Next Earning Date: | 01-07-2026 |
| Revenue: | $300,718,000 | Revenue Growth: | 2.73% |
| Revenue Growth (this year): | 8.18% | Revenue Growth (next year): | 5.15% |
AI-Powered ANGO Daily Prediction
Machine learning model trained on 25+ technical indicators
AI Recommendation
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of AngioDynamics Inc. (ANGO)
SVP, Chief Legal Officer
Avg Cost/Share
$11.81
Shares
10,000
Total Value
$118,100.00
Owned After
93,597
SEC Form 4
EVP and CFO
Avg Cost/Share
$11.16
Shares
890
Total Value
$9,932.40
Owned After
256,629
SEC Form 4
President and CEO
Avg Cost/Share
$11.15
Shares
10,000
Total Value
$111,500.00
Owned After
882,529
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Weiss Lawrence T | ANGO | SVP, Chief Legal Officer | Oct 21, 2025 | Buy | $11.81 | 10,000 | $118,100.00 | 93,597 | |
| Trowbridge Stephen A | ANGO | EVP and CFO | Oct 13, 2025 | Buy | $11.16 | 890 | $9,932.40 | 256,629 | |
| Clemmer James C | ANGO | President and CEO | Oct 9, 2025 | Buy | $11.15 | 10,000 | $111,500.00 | 882,529 |
Compare ANGO vs Leading Stocks
See how ANGO stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "ANGO AngioDynamics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.